ArticleNutrition journal2025
The prognosis value of geriatric nutritional risk index and associated genes in elderly patients with locally advanced rectal cancer following neoadjuvant chemoradiotherapy.
Article in Nutrition journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
purposeThis study evaluated the predictive value of nutritional and molecular biomarkers for assessing therapeutic response to neoadjuvant chemoradiotherapy (NCRT) and long-term outcomes in older adult patients with locally advanced rectal carcinoma (LARC).
methodsA retrospective cohort study analyzed 231 patients over 60 years old with LARC who underwent NCRT followed by radical resection between 2012 and 2018 at Fujian Medical University Union Hospital. The immunohistochemical (IHC) evaluation comprised 62 biopsy specimens from the same institution and 29 from the First Affiliated Hospital of Fujian Medical University.Transcriptomic data from GSE145037 (discovery cohort) and GSE35452 (validation cohort) were utilized to identify senescence-associated genes.
resultsfrom multivariate Cox regression identified pathological TNM stage (HR = 2.617, 95% CI 1.825-3.754, P < 0.001) and Geriatric Nutritional Risk Index (GNRI) (HR = 0.266, 95% CI 0.116-0.612, P = 0.002) as independent prognostic factors for disease-free survival (DFS), contributing to the development of a new DFS nomogram.Through random forest modeling, Epithelial Growth Factor Receptor (EGFR) overexpression and IQ Motif Containing GTPase Activating Protein 2 (IQGAP2) underexpression emerged as key aging-related biomarkers linked to GNRI. R2 platform analysis confirmed their prognostic significance, with elevated EGFR and low IQGAP2 correlating with reduced survival.Consistently, NCRT responders exhibited lower EGFR (P < 0.05) and higher IQGAP2 expression versus non-responders in both GSE145037 and GSE35452 datasets. External IHC validation reinforced these patterns in tumor microenvironment.
conclusionGNRI serves as a robust nutritional assessment tool for older adult LARC patients. The EGFR and IQGAP2 expression demonstrates dual utility in evaluating age-related malnutrition and predicting NCRT resistance, providing mechanistic insights for personalized therapeutic strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.